ClinicalTrials.gov
public full text
Public Domain
Vaginal Progesterone for the Prevention of Preterm Birth in Twins
This trial is a randomised, multi-centre, 2 x 2 factorial designed pilot trial with two factors of 200mg vs. 400mg progesterone self-administered daily from 11-14 weeks' gestation vs. 20-24 weeks' gestation, to compare the median gestational age (in days) at delivery between the comparison groups.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vaginal Progesterone to Reduce the Risk of Another Preterm Birth#871159
- The discordance between planned use and actual receipt of immediate postpartum depot medroxyprogesterone among low-income women.#358454
- Repeat Antenatal Steroids Trial#1161943
- Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate#966176
- Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies#841071
Record · ID 1127702
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive